Brésil: Dr. Maira CALEFFI

Elections-UICC Maira-Caleffi


MD and PhD. Dr Caleffi is Head of the Breast Centerat Hospital Moinhos de Vento and coordinator of Nucleo Mama Porto Alegre. She holds Pharmacy and Medicine degrees and a residency in Gynecology and Obstetrics. She completed her doctoral thesis at the University of London, and undertook postdoctoral studies in molecular biology in genetics and breast cancer at Vanderbilt University. Dr Caleffi is the founder and the olunteer President of IMAMA and FEMAMA. She is a member of The Brazilian Association of Palliative Care; Brazilian Breast Cancer Study Group (GBECAM); ASCO; Breast Health Global Initiative (BHGI); The Harvard School of Public Health - GTF.CCC; ISPOR; Unión Latinoamericana Contra el Cáncer de la Mujer (ULACCAM).


As a 20-year veteran in the breast cancer (BC) fight, my life as a doctor and as an individual has been guided by one vision: promote, maintain, educate and restore breast health and eradicate breast cancer as a life threatening disease. I founded IMAMA in 1993 to address the BC problem in my home state where we have the highest BC incidence and increasing mortality rates. FEMAMA, in 2006, was a consequence of the need for a national coalition (currently there are 53 NGOs). I alsostarted the ULACCAM with ACS and other Latin-American institutions. As a breastdedicated academic surgeon, I am involved in BC research projects for low and middleincome countries, improved risk factor and management models, and specialised technical training. International cooperation is needed to expand and share successfulexperiences with other countries not yet involved with UICC. I see the empowerment of patient groups as a key factor to successfully guarantee medical access and treatment in the future for underserved communities. Mutual cooperation and the need to strengthen our grass roots movements with the objective to reduce mortality rates are fundamental. My professional experience and my involvement with ASCO, BHGI, GTF, CCC, ISPORand the Brazilian NTCDs initiative allow me a unique view and insight into cancer issues. The tasks facing UICC in LMICs in the future are serious and challenging; we have to make cancer and its risk factors priorities in our governments' agendas. I am committed to UICC and to accomplishing this task.

Canada: Dr Heather BRYANT

Elections-UICC Heather-Bryant

Dr Bryant is a public health physician and epidemiologist whose career has focused on population-based cancer control. In 1990, at the Alberta Cancer Board, she implemented the firstpopulation-based breast screening programme in the province. As Vice President of Population Health and Information, she led the cancer registry, population-based research, active screening and prevention programmes, and implementation of the patient electronic health record. In 2008, she joined the Canadian Partnership Against Cancer as Vice President Cancer Control, and is implementing the Canadian cancer control strategy with partners throughout the country. She has chaired many national committees in cancer control, screening, and research.


My work in cancer control has built partnerships with a wide range of stakeholders in cancer prevention, screening and care delivery systems – the public, policymakers, professionals, health agencies, and many others – and mobilising these teams to reach significant cancer control outcomes. In my current position with the CanadianPartnership Against Cancer (CPAC), a non-governmental agency mandated to implement the national cancer control strategy, it is critical to build relationships that allow us to synergize activity and accelerate progress, while recognising that the actual care and healthcare management decisions are made by our partners in their own jurisdictions. This is similar to the potential global role of the UICC, and thus I believe this experience will be of value. I have had several international roles, including membership on the Governing Council for the International Agency for Research on Cancer (IARC), as an executive member of the International Association of Cancer Registries (IACR) (contributing to the measurement of the global cancer burden), as a Board Member for the International Cancer Benchmarking Programmeme (an international analysis of survival and public attitudes towards cancer), and on a cancer control working group for the World Health Organisation (WHO). With the UICC, I have been a member of the Strategic Coordinating Committee (attending Board meetings), co-led the Prevention stream for the 2010 UICC Congress, and co-chaired the Scientific ProgrammeCommittee for the 2012 Congress. I look forward to assisting the UICC to develop significant global leadership in cancer control as a Board Member.

Etats-Unis: M. Greg BONTRAGER

Elections-UICC Greg-Bontrager


As the chief operating officer for theAmerican Cancer Society, Greg Bontrager oversees operations for the world’s largest voluntary health organisation. He provides leadership and direction to all functions of the Society, including its expanding global endeavours. He also supervises the Society’s non-partisan 501(c)(4) advocacy affiliate, theAmerican Cancer Society Cancer Action Network. Mr Bontrager has worked for ACS for over 20 years. Since becoming enterprise COO, he has represented the Society at numerous international events and his interest in expanding the Society’s global mission is well known. He presently oversees the Society’s initiative to develop an enterprise-wide global strategy.


The American Cancer Society values its longstanding relationship with the UICC as a member and strategic partner. I would be honoured to contribute my time and talents towards furthering the UICC’s mission, and believe I could do so most effectively in the following priority areas: • Transforming the global landscape for cancer control and impact: In 2010, our CEO Dr John Seffrin announced his intention to strategically reinvent the American Cancer Society by building an ever-better platform for maximizing mission delivery. Dr Seffrin refers to me as his partner in this endeavour and I am proud of my role in providing a more effective, efficient and nimble platform from which to advance the Societys domestic and global mission. • High-level global conferences, roundtables and meetings: As a key member of the Society’s delegations to many UICC conferences and global corporate leadership events in Asia, Latin America, Africa and Europe, I have engaged corporate leaders on the need to address the global tobacco threat, prioritise cancer control and promote the economic toll of cancer and other NCDs.• The Global Access to Pain Relief Initiative (GAPRI): I am particularly interested in this joint UICC/ACS initiative and would value greater involvement in achieving the goals and objectives of this important collaboration. If elected, I am confidentmy experience and knowledge of the cancer space, as well as the rigours of running a complex organisation within that space, will allow me to contribute greatly to the continued success of this renowned institution.

Australie: Pr Sanchia ARANDA

Elections-UICC Sanchia-Aranda


Professor Aranda has 30 years of experience in cancer control. She has worked as a clinician, educator and researcher, having developed a significant supportive care research programme at thePeter MacCallum Cancer Centre in Melbourne. She is currently working in a government organisation in a role designed to improve system performance. In this role her responsibilities span data collection, cancer information reporting and system innovation. Professor Aranda is the immediate past President of the International Society of Nurses in Cancer Care where she fostered developments in international cancer nursing ranging from tobacco control programmes to train the trainer programmes in clinical leadership.


I have 16 years of board experience with the International Society of Nurses in Cancer Care with responsibility for constitutional reform and complete governance rethinking to ensure board effectiveness. My international skills include the development of successful funding submissions to support cancer control programmes, international conference management including scientific programme development and overallconference oversight. I am passionate about development of the cancer workforce in low resource countries and experienced in working with health professionals to develop sustainable programmes relevant to local needs. I am also interested in the GAPRI initiative. I have led the development of an international manual on pain control for health professionals in the past and my research programme involves studies to improve pain management. In my current role I have responsibility for cancer registries relevant to the UICC targets around improving measurement of the global cancer burden. In my two years on the board of UICC I have been on the scientific programmecommittees for China and Montréal World Cancer Congresses, leading a track for Montréal. I am building links between ISNCC and UICC around cancer education, bringing to the table a range of resources for cancer and palliative care developed in Australia that will be available to UICC work at no cost. I am a member of the UICCmembership committee and actively promote UICC membership. I am also working to support the development of a more active and engaged board. I also supported the promotion of World Cancer Day in Australia.

Nouveau board pour l’UICC

Nouveau Board

A la veille du Congrès Mondial contre le cancer, les membres de l’UICC se sont réunis pour leur Assemblée Générale biannuelle. A cette occasion, ils ont élu leur nouveau Board pour les deux prochaines années. Le Pr. Jacqueline Godet et M. Saïd Mchangama ont représenté la Ligue française contre le cancer et l’ALIAM.

L’ALIAM félicite tous les élus et se réjouit de l’élection du premier francophone à cette haute instance de l’UICC depuis nombreuses années, le Pr. Gilbert Lenoir.

Voici la composition du nouveau Board:

Professor Mary Gospodarowicz (Canada), President
Dr Eduardo Cazap (Argentina), Immediate Past President
Dr Tezer Kutluk (Turkey), President-Elect
Dr Samia Al-Amoudi (Saudi Arabia)
Dr Benjamin O. Anderson (United States)
Prof. Sanchia Aranda (Australia)
Mr Greg Bontrager (United States)
Dr Heather Bryant (Canada)
Dr Maira Caleffi (Brazil)
Dr Jamal Khader (Jordan)
Dr Felicia Knaul (Mexico)
Prof. Gilbert Lenoir (France)
Mrs Anne-Lise Ryel (Norway)
Dr Luiz Antonio Santini (Brazil)
Dr Kazuo Tajima (Japan)
Mr Douglas E. Ulman (United States)